(A) Schematic representation of CaMKIIα domain arrangement (top). Yellow circles indicate phosphorylation sites. CaMKIIα holoenzyme structure (bottom, PDB:5u6y). (B) Cartoon representation of …
Uncropped blots used in panel Figure 1E.
(A) Blots of pT286 detection on CaMKIIKD (4 μM) after phosphorylation with CaMKIIWT (10 nM) in the presence of ATP:Mg2+ and low Ca2+:CaM concentrations (100 nM). Each time point is done in …
Uncropped blots used for constructing the curves in Figure 1D and Figure 1—figure supplement 1E.
(A) Gels of CaMKIIKD phosphorylation detection in the presence of ATP:Mg2+ and low Ca2+:CaM concentrations (100 nM). Each time point is done in triplicates. (B) Gels of CaMKIIKD phosphorylation …
Uncropped gels used for constructing the curves in Figure 1—figure supplement 2C.
(A) Graph showing dependence of CaMKIIKD phosphorylation on CaMKIIWT concentration on a linear timescale. Each fit used the two-component exponential function (see Materials and methods for …
Uncropped blots of examples of immunoblotting used to construct curves in Figure 1—figure supplement 3A–C.
(A) Replicate 1 showing western blot detection of phosphorylation development on T286 of CaMKIIKD over the course of 60 min catalyzed by 0.5 nM CaMKIIWT. Left panel is showing detection of CaMKII by …
Uncropped blots used for constructing the curves in Figure 1—figure supplement 3A–C for 0.5 nM CaMKIIWT.
(A) Replicate 1 showing western blot detection of phosphorylation development on T286 of CaMKIIKD over the course of 60 min catalyzed by 2 nM CaMKIIWT. Left panel shows detection of CaMKII by …
Uncropped blots used for constructing the curves in Figure 1—figure supplement 3A–C for 2 nM CaMKIIWT.
(A) Replicate 1 showing western blot detection of phosphorylation development on T286 of CaMKIIKD over the course of 60 min catalyzed by 10 nM CaMKIIWT. Left panel shows detection of CaMKII by …
Uncropped blots used for constructing the curves in Figure 1—figure supplement 3A–C for 10 nM CaMKIIWT.
(A) Western blot detection of phosphorylation development on T286 over time when CaMKIIKD is incubated with 100 nM CaMKIIWT. Reaction at each time point is done in triplicate. The triplicates for 1, …
Uncropped blots used for constructing the curves in Figure 1—figure supplement 3A–C for 100 nM CaMKIIWT.
(A) Position of F394 residue (purple) in the hub domain of CaMKIIα (PDB: 5u6y), showing orientation towards the interface between adjacent hub domains within one hub ring. (B) Coomassie stained gel …
Uncropped Coomassie stained gels used in panel Figure 2B.
(A) Gels of CaMKIIKD phosphorylation detection by UV treated CaMKIIF394BzF. Each time point is done in triplicates. These data are used for Figure 2C. (B) Gels of CaMKIIKD phosphorylation detection …
Uncropped images of radioactive gels used to construct the curves in Figure 2C.
(A) Coomassie stained gel showing UV-dependent oligomerization of CaMKIIH418BzF. (B) Phosphorylation of CaMKIIKD by UV-treated or -untreated CaMKIIH418BzF. Langmuir fit determined half-maximum times …
Uncropped images of Coomassie stained and radioactive gels used to construct the curves in Figure 2—figure supplement 2B.
(A) Gels of CaMKII substrate (GST-Syn) phosphorylation by UV-treated CaMKIIF394BzF. Each time point is done in triplicate. (B) Gels of CaMKII substrate (GST-Syn) phosphorylation by control CaMKIIF394…
Uncropped images of radioactive gels used in Figure 2—figure supplement 3.
(A) Schematic representation of the experiment performed in panel (B) and possible outcomes. (B) Western blot detection of potential CaMKIIKD-AviTag incorporation in CaMKIIF394BzF holoenzymes. Lane …
Uncropped blots used in panel Figure 3B.
(A) Coomassie stained gel of CaMKIIF394BzF and CaMKIIKD crosslinking used in Figure 3B. (B) Western blot detection of potential CaMKIIWT-AviTag incorporation in CaMKIIF394BzF holoenzymes. Blue …
Uncropped Coomassie stained gels and blots used in Figure 3—figure supplement 1.
(A) Schematic representation of crosslinking experiments and expected outcomes. In the case of subunit exchange, a flat profile of intersubunit crosslinks is expected, whereas for inter-holoenzyme …
(A) Zoomed-in exemplary MS1 spectrum showing uni-isotopic (homotypic) and mixed-isotopic (heterotypic) crosslinks. The ratio of mixed-isotopic and uni-isotopic crosslinks is calculated using the …
Kinase domain (from the 5u6y PDB structure) with regulatory domain (orange) docked. 6 Lysine residues that gave heterotypic crosslinked peptides including P-Thr286 (DSS link to Lys291) are indicated …
(A) Holoenzyme structure with two neighboring subunits (green and purple) indicated (PDB: 5u6y). Hub domain is in light blue, regulatory segment (docked) in orange. (B) Basal crosslinks between …
Heterotypic DSS crosslinks between kinase domains have plausible lengths (less than 20 Å) when one kinase domain from a holoenzyme is interdigitated into the structure of another holoenzyme. Hub …
(A) Schematic representation of CaMKII in vitro enzymatic labeling with maleimide dyes and biotin, and TIRF experimental set-up. (B) Representative TIRF images of unactivated (basal) CaMKIIWT sample …
(A) Absence of colocalization between differently labeled CaMKIIWT holoenzymes in the absence of Mg2+:ATP. (B) Absence of colocalization between differently labeled CaMKIIWT holoenzymes upon …
(A) Absence of colocalization between CaMKIIKD and CaMKIIWT in basal conditions. (B) Colocalization of CaMKIIKD and CaMKIIWT upon activation. (C) Absence of colocalization between differently …
(A) Mass distribution of 400 nM CaMKIIWT under basal conditions (red curve). Blue curve is multi- Gaussian fit (shown separately on lower graph). Red curve in upper graph is the fit residual. (B) …
(A) Two replicates of the particle mass distribution of 400 nM CaMKIIWT under basal conditions (red curve). Blue curve is multi-Gaussian fit (shown separately on lower graph). Red curve in upper …
(A) Particle mass distribution of 400 nM CaMKIIKD under basal conditions. (B) Particle mass distribution of 400 nM CaMKIIKD under activating conditions. (C) Western blot detection of pT286 on CaMKIIK…
Uncropped blots used in Figure 7—figure supplement 2C.
Crosslinked peptides identified by MS X-linking.
(A) Homotypic crosslinks (basal, 30 min). (B) Homotypic crosslinks (basal, 150 min). (C) Heterotypic crosslinks (basal, 30 min). (D) Heterotypic crosslinks (basal, 150 min). (E) Homotypic crosslinks (activated, 30 min). (F) Homotypic crosslinks (activated, 150 min). (G) Heterotypic crosslinks (activated, 30 min). (H) Heterotypic crosslinks (activated, 150 min) (I) pT286 Heterotypic peptides (30 min). (J) pT286 Heterotypic peptides (150 min).